$TDG

TransDigm Group INC

Insider trades
5
1
0
$12.3M
Howley W Nicholas
100%
See all $TDG insider activity →
Low

Aerospace Stocks Q2 Results: Benchmarking Rocket Lab (NASDAQ:RKLB)

The article benchmarks Q2 results for aerospace stocks. AerSale (NASDAQ:RKLB) reported revenue of $70.93M, down 33.9% YoY and 12.7% below analyst expectations, with misses on EBITDA and EPS. TransDigm (NYSE:TDG) posted $2.74B revenue, up 22.5% YoY, beating estimates and guidance. Redwire (NYSE:RDW) reported $117.1M revenue, up 89.6% YoY, beating estimates and guidance.

5 Must-Read Analyst Questions From TransDigm’s Q2 Earnings Call

TransDigm reported Q2 revenue of $2.74B vs $2.67B estimates and adjusted EPS of $10.87 vs $10.30, with adjusted EBITDA $1.45B. The company raised full-year guidance to $10.51B revenue and $41.04 adjusted EPS at the midpoint. Analysts asked about right-to-repair legislation, defense M&A, aftermarket vs flight activity, and margin outlook.

TransDigm’s (TDG) Earnings Soared, So Why Did The Stock Sink?

TransDigm Group (NYSE:TDG) reported fiscal Q3 results on Aug. 4. Net sales rose 23% to $2,741 million and adjusted EPS increased 13% to $10.87. Management raised full-year guidance, lifting the adjusted EPS midpoint by $1.52 to $40.62-$41.46, but the stock fell after the release amid margin pressure from acquisitions and added debt.

TDG sentiment & insider activity

Over the past 7 days, alphai's AI scored 6 news stories mentioning TDG (TransDigm Group INC). Coverage has skewed bullish: 5 bullish, 1 neutral, and 0 bearish.

Recent TDG coverage spans earnings, financial news and market movers.

In the last 30 days, TDG insiders filed 12 SEC Form 4 transactions — no purchases and 12 sales ($12.3M). The most active reporter was Howley W Nicholas with 12 filings. 100% of those filings were made under pre-arranged Rule 10b5-1 plans.

What's driving TDG

  • A revenue beat plus organic beat and full-year EBITDA guidance beat supports continued positive positioning in TDG.

    yahoo.com · Aug 16, 2026

  • Guidance raises and clearer margin framing can support near-term estimates, but uncertainty around right-to-repair and aftermarket vs flight trends limits conviction.

    yahoo.com · Aug 13, 2026

  • Post-earnings selloff despite raised guidance suggests investors are discounting margin dilution, leverage, or valuation rather than growth.

    yahoo.com · Aug 11, 2026

  • Guidance raise plus active M&A and buybacks suggest improving near-term earnings power, but leverage and DOJ-driven deal risk remain key swing factors.

    fool.com · Aug 11, 2026

  • The earnings datapoints support a bullish read-through on near-term fundamentals, though the article frames the post-report pullback as an opportunity.

    fool.com · Aug 11, 2026

alphai scores every news story that mentions TDG with an AI model for sentiment and relevance, and aggregates insider trades from TransDigm Group INC's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $TDG

Score
$RKLBLow

Aerospace Stocks Q2 Results: Benchmarking Rocket Lab (NASDAQ:RKLB)

The article benchmarks Q2 results for aerospace stocks. AerSale (NASDAQ:RKLB) reported revenue of $70.93M, down 33.9% YoY and 12.7% below analyst expectations, with misses on EBITDA and EPS. TransDigm (NYSE:TDG) posted $2.74B revenue, up 22.5% YoY, beating estimates and guidance. Redwire (NYSE:RDW) reported $117.1M revenue, up 89.6% YoY, beating estimates and guidance.

$TDGMedAI 8/10

5 Must-Read Analyst Questions From TransDigm’s Q2 Earnings Call

TransDigm reported Q2 revenue of $2.74B vs $2.67B estimates and adjusted EPS of $10.87 vs $10.30, with adjusted EBITDA $1.45B. The company raised full-year guidance to $10.51B revenue and $41.04 adjusted EPS at the midpoint. Analysts asked about right-to-repair legislation, defense M&A, aftermarket vs flight activity, and margin outlook.

$TDGMedAI 8/10

TransDigm’s (TDG) Earnings Soared, So Why Did The Stock Sink?

TransDigm Group (NYSE:TDG) reported fiscal Q3 results on Aug. 4. Net sales rose 23% to $2,741 million and adjusted EPS increased 13% to $10.87. Management raised full-year guidance, lifting the adjusted EPS midpoint by $1.52 to $40.62-$41.46, but the stock fell after the release amid margin pressure from acquisitions and added debt.

$TDGHighAI 9/10

TransDigm (TDG) Q3 2026 Earnings Call Transcript

TransDigm (TDG) reported Q3 FY2026 revenue of $2.741B (+23%) and adjusted EPS of $10.87 (+13%). EBITDA was $1.447B (+19%) with a 52.8% margin. Management raised full-year guidance, including revenue midpoint $10.51B and adjusted EPS $41.04. It withdrew from the Stellant deal after DOJ signaled it would challenge the transaction.

$TDGMedAI 8/10

Transdigm Group Q3 Earnings Call Highlights

TransDigm (NYSE:TDG) reported Q3 EBITDA As Defined margin of 52.8% and organic growth of about 13%. Free cash flow was about $870M in the quarter and $2.1B YTD; full-year FCF outlook raised to about $2.6B. Q3 included $980M of share repurchases. Management raised FY2026 revenue to $10.51B and EPS to $41.04 midpoint, citing Boeing and Airbus production rates.

$TDGMedAI 8/10

TransDigm Group Incorporated Q3 2026 Earnings Call Summary

TransDigm reported Q3 2026 results with commercial aftermarket revenue up 17% and double-digit growth across channels. Management raised full-year revenue guidance to $10.51B and EBITDA to $5.52B, targeting a 52.5% margin. The company withdrew from a Stellant acquisition due to DOJ litigation hurdles and bought Prince & Izant for $1.1B.

Why TransDigm (TDG) Stock Is Down Today

TransDigm (NYSE: TDG) shares fell about 2.6% after Stifel downgraded the stock to Hold from Buy and cut its price target, citing concerns including slower M&A, higher legislative risk from right-to-repair laws, and potential weaker aerospace demand. The move followed TDG Q3 revenue of $2.74B, up 23% YoY.

$BMYMed

Best Buy downgraded, Bristol Myers upgraded: Wall Street's top analyst calls

Analyst actions highlighted: Argus upgraded Bristol Myers (BMY) to Buy, $75 target, citing margin improvement and raised 2026 guidance. Freedom Broker upgraded McDonald's (MCD) to Buy, $305 target, on softer revenue and comps. Morgan Stanley upgraded Humana (HUM) to Equal Weight, $370 target. Jefferies downgraded Best Buy (BBY) to Hold, $85 target. Others included upgrades/downgrades for several stocks with updated price targets.

Related tickers

TDG — TransDigm Group news & insider trades | alphai